16 results · 40ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DePuy ATTUNE™ Knee System

FDA 510(k)
FDA Class 2 ·Orthopedic

Crosperio RX PTA Balloon Dilatation Catheter

FDA 510(k)
FDA Class 2 ·Cardiovascular

SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD), MODEL SV-S23BL35VS

FDA 510(k)
FDA Class 2 ·General Hospital

SHIDEN HP

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·June 4, 2019

UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM

FDA Adverse Event
Malfunction ·BECKMAN COULTER, INC.·Product code JJE·September 9, 2011

LIFEVEST WCD 4000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL MANUFACTURING CORPORATION·Product code MVK·September 4, 2014

POWERED WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code ITI·July 29, 2013

SHIDEN HP

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·March 1, 2024

SHIDEN

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·July 10, 2020

DIVA

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·July 7, 2020

DIVA

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·July 7, 2020

Staclot LA 20 (REF 00594) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).

FDA Enforcement
Class II ·Terminated·Diagnostica Stago, Inc.·December 26, 2018

SHIDEN HP

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·April 18, 2022

SHIDEN

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·September 2, 2021

SHIDEN

FDA Adverse Event
Injury ·KANEKA CORPORATION·Product code LIT·January 6, 2022

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014